Market players operating in the phenylephrine hydrochloride market is as mentioned below:
Aarti Pharmalabs Limited
SNA Healthcare Private Limited
Ralington Pharma
Cornileus Pharmaceuticals (P) Ltd.
Shenzhen Oriental Pharmaceutical Co. Ltd.
Unichem Laboratories Ltd.
Kavya Pharma
Transo-Pharm
LGM Pharma
Divi's Laboratories Limited
Authors:
Mariam Faizullabhoy, Gauri Wani
Frequently Asked Questions (FAQ) :
Phenylephrine hydrochloride (HCL) market size was USD 777.6 million in 2022 and may reach USD 1.6 billion by 2032 driven by the consistent demand for decongestant medications to counter respiratory ailments.
The nasal decongestion application segment held 29.5% share of the phenylephrine hydrochloride industry in 2022 due to the surging need for effectively reducing the swelling and congestion in common cold, allergies, sinusitis, and hay fever.
North America recorded 38.9% share of the global phenylephrine hydrochloride market in 2022 owing to higher importance in the pharmaceutical sector, primarily due to its key role in the production of nasal decongestant medications.
Some of the well-known phenylephrine HCL market players are Cornileus Pharmaceuticals (P) Ltd, Aarti Pharmalabs Limited, Ralington Pharma, SNA Healthcare Private Limited, Shenzhen Oriental Pharmaceutical Co. Ltd., Unichem Laboratories Ltd., and Kavya Pharma.